⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Aligos Therapeutics, Inc. Common Stock

$2.06
+0.08 (+4.04%)

Volume:

54.001K ($113.62K)

Market Capitalization:

$12.86M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Aligos Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

-0.04(-1.90%)
Open$2.10
Close$2.06
Low$2.06
Low Change-0.04 (-1.90%)
High$2.10
High Change+0.00 (+0.00%)
Range$0.04
Volume1.209K
Dollar Volume$2.49K

Regular Trading Hours

+0.02(+0.72%)
Open$2.09
Close$2.11
Low$1.98
Low Change-0.11 (-5.26%)
High$2.25
High Change+0.16 (+7.42%)
Range$0.27
Volume52.442K
Dollar Volume$110.39K

Premarket

+0.05(+2.45%)
Open$2.07
Close$2.12
Low$2.07
Low Change0.00 (0.00%)
High$2.12
High Change+0.05 (+2.45%)
Range$0.05
Volume350
Dollar Volume$742.00

After Hours Yesterday

+0.00(+0.00%)
Open$1.98
Close$1.98
Low$1.98
Low Change0.00 (0.00%)
High$1.98
High Change+0.00 (+0.00%)
Range$0.00
Volume1.308K
Dollar Volume$2.59K

Regular Trading Hours Yesterday

-0.23(-10.41%)
Open$2.21
Close$1.98
Low$1.92
Low Change-0.29 (-13.12%)
High$2.32
High Change+0.11 (+4.80%)
Range$0.40
Volume113.937K
Dollar Volume$225.60K

Premarket Yesterday

-0.12(-4.79%)
Open$2.40
Close$2.29
Low$2.29
Low Change-0.12 (-4.79%)
High$2.44
High Change+0.04 (+1.67%)
Range$0.16
Volume849
Dollar Volume$1.94K

Aligos Therapeutics Top Trades

Aligos Therapeutics's top trade so far today returned +8.49%, while the top short trade returned -8.24%.

Aligos Therapeutics Moving Averages

5 Day Moving Average (SMA5)$2.96
10 Day Moving Average (SMA10)$3.87
20 Day Moving Average (SMA20)$4.38
50 Day Moving Average (SMA50)$5.02
100 Day Moving Average (SMA100)$5.45
200 Day Moving Average (SMA200)$6.03

Aligos Therapeutics Statistics

Average Volume (30 Days)51.71K
P/E Ratio (Current)-.20
EPS (Current)-$10.61
Dividend Yield0.00%
Free Cash Flow-$68.66M
Cash Ratio1.59
Current Ratio1.77
Quick Ratio1.77
Debt to Equity0.01
Enterprise Value-$17.54M
EV to EBITDA0.25
EV to Sales-0.52
Price to Book1.19
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales0.40
Return on Assets-1.40%
Return on Equity-5.86%

Aligos Therapeutics Stock Splits

There has been 1 stock split for Aligos Therapeutics (ALGS). The reverse stock split occured on August 19, 2024 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
Aug 19, 2024Reverse25:1

Aligos Therapeutics Dividends

There have been no dividends for Aligos Therapeutics (ALGS).